Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04508634Phase 4Unknown
Phase 4, randomised, open-label trial (2 arms), sponsored by Shanghai Tenth People's Hospital. Primary endpoints: Homeostatic Model Assessment for Insulin Resistance at 3 months, Plasma Metabolites Concentration at 3 months and 2 more. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04508634.